Model of the oxidation-induced amyloid formation and disassembly mechanism of p16. Credit: Nature Communications (2024). DOI: 10.1038/s41467-024-49581-7 Researchers from the University of Otago, Christchurch, have spearheaded the discovery of a protein function which has the potential to guide the development of novel cancer treatment options and improve the diagnosis of various cancers. The research, carried out alongside Dr. Vanessa Morris from the University of Canterbury’s School of Biological Sciences as well as researchers in Australia and Denmark, centers on the activity of a tumor- suppressing protein called p16. The discovery, published in Nature Communications and first authored by University of Read More
No comments:
Post a Comment